CYAD
Celyad Oncology SA American Depositary Shares
CYAD
CYAD
Delisted
CYAD was delisted on the 18th of May, 2023.
7 hedge funds and large institutions have $768K invested in Celyad Oncology SA American Depositary Shares in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$13.7K |
| 2 |
JPMorgan Chase & Co
New York
|
+$12K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$8K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$5.94K |
| 5 |
Morgan Stanley
New York
|
+$1.23K |
Top Sellers
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$419K |
| 2 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$62.8K |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$60K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ECM
1
Endurant Capital Management
San Mateo,
California
| $596K | -$62.8K | -15,311 | -10% |
|
|
2
Morgan Stanley
New York
| $102K | +$1.23K | +300 | +1% |
|
|
3
Wells Fargo
San Francisco,
California
| $32K | +$5.94K | +1,445 | +23% |
|
|
4
UBS Group
Zurich,
Switzerland
| $18K | +$13.7K | +3,335 | +316% |
|
|
5
JPMorgan Chase & Co
New York
| $12K | +$12K | +3,000 | New |
|
|
6
Osaic Holdings
Scottsdale,
Arizona
| $8K | +$8K | +1,880 | New |
|
|
7
Victory Capital Management
San Antonio,
Texas
| – | -$419K | -79,902 | Closed |
|
|
OMC
8
Old Mission Capital
Chicago,
Illinois
| – | -$60K | -11,323 | Closed |
|